Evidence map›Paper›PMID 33933257›Full record

ArticleThe Journal of thoracic and cardiovascular surgery2022

Allergic response to medical products in patients with alpha-gal syndrome.

Kasinath V Kuravi, Lori T Sorrells, Joseph R Nellis, Farzana Rahman, Anneke H Walters, Robert G Matheny, Shailesh K Choudhary, David L Ayares, Scott P Commins, John R Bianchi and 1 more

Abstract read
In one paragraph

Article in The Journal of thoracic and cardiovascular surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Unusual Causes of Food-Induced Anaphylaxis - A Review.Indian dermatology online journal · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Pre-clinical strategies and emerging technologies driving advances in the alpha-gal syndrome.Allergology international : official journal of the Japanese Society of Allergology · 2025
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Kasinath V KuraviRevivicor Incorporated, United Therapeutics, Blacksburg, Va.
Lori T SorrellsDuke Congenital Heart Surgery Research and Training Laboratory, Durham, NC.
Joseph R NellisDuke Congenital Heart Surgery Research and Training Laboratory, Durham, NC.
Farzana RahmanRevivicor Incorporated, United Therapeutics, Blacksburg, Va.
Anneke H WaltersRevivicor Incorporated, United Therapeutics, Blacksburg, Va.
Robert G MathenyCorMatrix Cardiovascular Inc, Roswell, Ga.
Shailesh K ChoudharyDivision of Allergy, Immunology, and Rheumatology, University of North Carolina, Chapel Hill, NC.
David L AyaresDivision of Allergy, Immunology, and Rheumatology, University of North Carolina, Chapel Hill, NC.
Scott P ComminsDivision of Allergy, Immunology, and Rheumatology, University of North Carolina, Chapel Hill, NC.
John R BianchiRevivicor Incorporated, United Therapeutics, Blacksburg, Va.
Joseph W TurekDuke Congenital Heart Surgery Research and Training Laboratory, Durham, NC; Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University, Durham, NC. Electronic address: joseph.turek@duke.edu.

Funding

Understanding alpha-gal red meat allergyR01AI135049 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Scott Palmer Commins · 2018 to 2026
$5.1M
NIAID NIH HHS R01 AI135049
6 · The paper itself

Abstract

backgroundGalactose-α-1,3-galactose (alpha-gal) is a carbohydrate that is ubiquitously expressed in all mammals except for primates and humans. Patients can become sensitized to this antigen and develop alpha-gal syndrome (AGS), or a red meat allergy. Symptoms range from generalized gastroenteritis and malaise to anaphylaxis, and in endemic areas, the prevalence can be as high as 20%. Although AGS patients commonly avoid alpha-gal by avoiding meat, patients have also developed symptoms due to animal-derived medical products and devices. With the rise in transcatheter aortic valve replacement, we investigate the immunogenicity of common cardiac materials and valves.

objectiveTo assess the in vitro immunoglobulin E response toward common medical products, including cardiac patch materials and bioprosthetic valves in patients with AGS.

methodsImmunoblot and immunohistochemistry techniques were applied to assess immunoglobulin E reactivity to various mammalian derived tissues and medical products for patients with AGS.

resultsAGS serum showed strong reactivity to all of the commercially available, nonhuman products tested, including various decellularized cardiac patch materials and bioprosthetic aortic valves. AGS serum did not react to tissues prepared using alpha-gal knockout pigs.

conclusionsDespite commercial decellularization processes, alpha-gal continues to be present in animal-derived medical products, including bioprosthetic valves. Serum from patients with AGS demonstrates a strong affinity for these products in vitro. This may have serious potential implications for sensitized patients undergoing cardiac surgery, including early valve failure and accelerated coronary artery disease.

Indexed as

AnaphylaxisFood HypersensitivityAnimalsGalactoseHumansImmunoglobulin EMammalsSwineSyndromeGalactoseImmunoglobulin Eallergyalpha-galalpha-gal syndromebioprosthetic valvechronic inflammationcoronary artery diseaseearly valve degradation

Identifiers

PMID33933257
PMCPMC9673037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.